MAY 08, 2018 6:47 PM PDT

Promising Treatment for Alcoholism

WRITTEN BY: Nouran Amin

Investigators at the University of Texas at Austin have successfully used animal models to examine a drug believed to inhibit the symptoms of alcohol withdrawal, ultimately treating alcoholism.

Alcoholism is a chronic disease affecting more than 15 million Americans and many more across the globe. More specifically, it is a disease characterized by the preoccupation of alcohol. Although there exists an array of drugs to combat alcohol addiction, they are not always effective and tend to have negative side effects.

Now, the drug believed to treat alcohol addiction known as JVW-1034, was studied to work in worms and rats that exhibited symptoms of alcohol addiction. These results can eventually be illustrated in human patients with little to no side effects. However, UT-Austin researchers noted that the drug will need to go through intensive monitoring before any clinical trials on humans can occur.

JVW-1034 is unique because it works to inhibit an unconventional molecular pathway that produces no side effects. “There’s clearly a huge need for something different and better,” explains UT Austin researchers and co-author of the study, James Sahn. “That’s where our approach shines. It’s modulating a pathway that doesn’t seem to be associated with any of the other drugs that are available.”

Although JVW-1034 is promising, researchers are hoping to optimize the efficacy of the drugs chemical properties. They are planning to create a pill that can someday be able to block alcohol withdrawal symptoms and alcohol cravings in order to help affected individuals avoid relapse. Unfortunately, a creation of such pill is still unclear in its promise to treat alcoholism. This is primarily because alcoholism is a complex disease with a multitude of factors that may contribute to its pathophysiology. Regardless, a drug taken for a chronic disease can still be effective in treating stress and being beneficial for individuals affected by alcoholism.

“If we could achieve a medication that is effective for more people and doesn’t have the negative side effects that some of these drugs have, that would be game-changing,” says Stephen Martin, professor of chemistry at UT Austin and senior author.

Sources: University of Texas at Austin, Neuropsychopharmacology

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
NOV 14, 2021
Genetics & Genomics
Cancer Drug Target Could Actually Worsen Disease
NOV 14, 2021
Cancer Drug Target Could Actually Worsen Disease
Cancer drugs have been developed that target an enzyme, Shp2. But that enzyme has a more complex role than we knew.
NOV 16, 2021
Health & Medicine
Psilocybin and Cannabis to Treat Anxiety and Addiction
NOV 16, 2021
Psilocybin and Cannabis to Treat Anxiety and Addiction
Johns Hopkins University Center for Psychedelic and Consciousness Research just received a $4.9 million grant to study h ...
NOV 19, 2021
Neuroscience
Exercise Fights Inflammation by Increasing Body's Own Cannabis Production
NOV 19, 2021
Exercise Fights Inflammation by Increasing Body's Own Cannabis Production
Exercise increases the body’s production of endocannabinoids, which in turn reduces inflammation and pain in condi ...
DEC 13, 2021
Cancer
Mistletoe: Parasite, Symbol of Romance, or Cancer Treatment?
DEC 13, 2021
Mistletoe: Parasite, Symbol of Romance, or Cancer Treatment?
As we approach the winter season, decorative swigs of mistletoe are starting to make their holiday debut.  You may ...
DEC 10, 2021
Drug Discovery & Development
Blood from Physically-active Boosts Memory in Sedentary Mice
DEC 10, 2021
Blood from Physically-active Boosts Memory in Sedentary Mice
Sedentary mice experience reduced neuroinflammation and improved cognitive abilities after receiving blood from physical ...
JAN 20, 2022
Immunology
Researchers Stumble Upon Cancer Drug While Studying Flesh-Eating Bacteria
JAN 20, 2022
Researchers Stumble Upon Cancer Drug While Studying Flesh-Eating Bacteria
  Scientists studying a neglected tropical disease have made a chance discovery—a promising therapeutic targe ...
Loading Comments...